Business

iBody provides an antibody generating service to companies’ R&D departments and academia, which need highly specific monoclonal antibodies that are difficult to obtain using conventional technologies. We also work on antibody mining together with clients as collaborative research for projects outside the scope of our packaging services.

iBody focuses on cancer, autoimmune diseases, and infectious diseases, where human antibodies play an important role in disease progression and suppression. We are also working on the discovery and development of new antibody therapeutics.
Using “Ecobody” technology, it is possible to obtain natural human antibodies that bind to human antigens in their in vivo form. Taking advantage of “Ecobody,” iBody can discover and develop therapeutics with excellent efficacy for diseases for which existing antibody-related drugs cannot elicit sufficient efficacy.